New World Medical Received EU Certification for Glaucoma Tools
The company has secured Medical Device Regulation certification for three of its primary ophthalmic products.
Updated on Oct. 6, 2026 in Biotech
Live Poll
Do you believe stricter medical device regulations improve the quality of care for patients?
New World Medical has successfully obtained Medical Device Regulation (MDR) certification within the European Union for three of its glaucoma products. This shift transitions these medical devices from the older Medical Device Directive framework to updated regulatory requirements.
Why it matters
The certification ensures continued compliance with stricter European Union regulatory standards, allowing the company to maintain access to the market. It represents a significant operational update for the manufacturer of ophthalmic surgical devices.
The certification covers the Ahmed Glaucoma Valve, Ahmed ClearPath, and KDB GLIDE. While these products are now certified, the company is still working to gain MDR approval for the Ahmed ClearPath ST, which is currently authorized in over 20 countries.
The players
New World Medical
Based in Rancho Cucamonga, California, this medical device company specializes in manufacturing products designed to treat glaucoma.
The details
New World Medical successfully navigated the transition to the updated European Union regulatory requirements by coordinating with a designated notified body. The three products were previously distributed under the older Medical Device Directive framework before meeting the new standards.
Timeline
October 6, 2026: New World Medical announced it received the new MDR certification.
The Tech Race
This move mirrors a broader industry effort to migrate legacy products into the current European Union Medical Device Regulation framework. It positions New World Medical to maintain its competitive footprint against other ophthalmic manufacturers operating in the EU market.
This certification ensures that surgeons and patients in the European Union continue to have uninterrupted access to the company's established glaucoma surgical tools. Users can expect the products to remain available for clinical use under the updated regulatory status.
The takeaway
Maintaining certification is a critical step for biotech firms looking to retain long-term market access in the European Union. Readers should note that these regulatory transitions are ongoing, as companies continue to update portfolios to meet evolving health safety standards.
Further reading
For more on industry regulatory trends, visit the Biotech section.
More information
Learn more about these medical devices on the New World Medical official website.
Live Poll
Do you believe stricter medical device regulations improve the quality of care for patients?
